DIOD · Diodes Incorporated · Stock research

Current Thesis

The July frame — a round-tripped re-rate trading below its breakout shelf — was overwritten by the 2026-08-05 print. Q2 revenue came in at $445.5M against $366.2M a year earlier and above the $435M ±3% guide set on 2026-05-07; non-GAAP EPS was $0.70 versus $0.60 consensus; GAAP gross margin 33.1% ($147.6M gross profit). The larger item is the Q3 guide: revenue approximately $510M ±3% against $471.25M consensus, GAAP gross margin 35.0% ±1%, adjusted EPS $0.95–$1.15 against $0.83 consensus. Layered on top, the 2026-07-14 agreement to buy ElevATE Semiconductor for $250M all-cash adds automated-test-equipment analog to a portfolio that had been sold as AI-server power and automotive content. Price closed $105.17 on 2026-08-07, back above the $101.96 June breakout base it lost on 2026-07-10 at $96.32, and 14.3% under the $122.76 adjusted 52-week high.

Bullish and bearish views on Diodes Incorporated

The model's bull view on Diodes Incorporated (DIOD), in brief: Guide re-acceleration, 2026-08-05: Q3 revenue ~$510M ±3% versus $471.25M consensus and $445.5M actual in Q2 — sequential acceleration after an already-accelerating quarter, not a stabilisation guide. The bear view: GAAP flattered the headline: Q2 GAAP diluted EPS was $1.00 on net income of $46.6M against non-GAAP EPS of $0.70. Both cases follow in full.

Bull Case

• Guide re-acceleration, 2026-08-05: Q3 revenue ~$510M ±3% versus $471.25M consensus and $445.5M actual in Q2 — sequential acceleration after an already-accelerating quarter, not a stabilisation guide.
• Margin step-up is the new claim: Q3 GAAP gross margin guided 35.0% ±1% off 33.1% posted in Q2. The company's stated 2028 framework was $2B revenue / 35%+ gross margin / $4+ non-GAAP EPS; a $510M quarter annualises above $2.0B (arithmetic on the guide midpoint, not a company forecast), which puts both framework markers in play roughly two years early.
• ElevATE, 2026-07-14: $250M all-cash for a San Diego fabless ATE analog designer; company says roughly $50M of revenue in year one and immediate accretion to revenue, margin and EPS, with close expected in 2H 2026. ATE demand is levered to test intensity on advanced logic and HBM — a different demand driver than the auto/industrial book.
• Cash generation held through the ramp: cash and short-term investments $442M at 2026-06-30, operating cash flow $68.5M and free cash flow $34.8M in Q2 — the $250M cash purchase price is covered by balance-sheet cash on the reported figures.
• Sell-side stayed constructive through the drawdown: Truist maintained Buy on 2026-08-06 while cutting its target to $133 from $139, versus a five-firm average target of $113 compiled 2026-08-03 with a Moderate Buy consensus.

Bear Case

• GAAP flattered the headline: Q2 GAAP diluted EPS was $1.00 on net income of $46.6M against non-GAAP EPS of $0.70. GAAP above non-GAAP runs the opposite way to the usual adjustment direction, and the reconciliation is not visible in the summary release data — the recurring number to compare against consensus is $0.70.
• Target cluster sits close to spot: the $113 average compiled 2026-08-03 is only modestly above the $105.17 close on 2026-08-07, and Truist trimmed $139 to $133 on the day after a beat-and-raise. Sell-side headroom compressed while the stock rallied.
• The June top has not been repaired: the 2026-06-18 high near $122.76 (adjusted) is intact, and the June breakdown printed intermediate shelves near $114.70 and $104.22 — overhead supply from June buyers sits between spot and the high.
• Insider distribution is recent history: five insiders sold May–June 2026, including CTO Francis Tang (~$1.72M) plus SVPs Emily Yang and Andy Tsong, Diodes Asia president Jin Zhao and corporate secretary R.D. White. No new Form 4s appear in the current window; the cluster still frames how management priced the last run.
• Deal risk is unresolved: the ElevATE transaction is signed and board-approved but subject to regulatory clearance, with only a 2H 2026 close window. Accretion is a promise until the closing 8-K lands.
• Beta dominates on risk-off days: the July leg from ~$122 to $96.32 was sector-wide semiconductor selling rather than company news, and nothing about the Q2 print changes that transmission.

Setup & Price Structure

Spot $105.17 (2026-08-07) sits 14.3% below the $122.76 adjusted 52-week high, roughly 15% above the $91.02 July range low, and above the $101.96 shelf that defined the June breakout and failed on 2026-07-10. RSI(14) is 64.5 — momentum restored without the >70 reading that marked the June high. The three-month return is still negative at -5.6%, so the recovery has recouped the July damage without reclaiming the June range.

Life-cycle: ACCELERATING, dated to 2026-07-14 (ElevATE) and 2026-08-05/06 (Q3 guide $510M ±3%, 35.0% gross-margin guide, Truist reiteration, DIOD named among Thursday's higher movers). This is a second acceleration inside an unrepaired top, so the label is conditional: rejection in the $114–117 supply band without a new high would argue the narrative has moved to MATURING instead.

Crowding and positioning observables, stated as observables: the earnings binary has already passed, removing the event risk that dominated the July setup and leaving no company-scheduled print until roughly early November; the consensus target average compiled 2026-08-03 is $113 against a $105.17 close; the most recent target action was a cut (Truist, $139 → $133, 2026-08-06) despite a beat; insider selling clustered May–June 2026 with no new filings since; and the stock has advanced roughly 9% off the 2026-07-10 close into a rising structure without yet testing the June high.

Catalyst Calendar (next 30 days)

• ~2026-08-10 (est.) — Q2 FY26 Form 10-Q. First look at the GAAP-to-non-GAAP reconciliation behind $1.00 versus $0.70, inventory position, and any financing arranged for the $250M ElevATE payment against $442M of cash and short-term investments.
• ~2026-08-26 (est.) — Nvidia fiscal Q2 print, the largest dated data-center capex signal inside the window. DIOD traded on sector beta through the July drawdown, and the AI-server content leg of the story is priced off the same capex line.
• Undated, 2H 2026 window — ElevATE closing 8-K. Regulatory clearance and close would move ~$50M of first-year revenue from promise to base.
• ~2026-11-04 (est.) — Q3 FY26 print. Outside the 30-day window but the only company-controlled test of the $510M ±3% revenue and 35.0% ±1% gross-margin guide.

What Would Change Our Mind

The structural question is whether the reclaim of the $101.96 June shelf holds now that the print is behind it. Losing it again would put the Q2 beat in the same category as the June breakout — a fundamental datapoint the tape refused to pay for. A daily close below $101 marks that failure; a weekly close below $96 takes out the 2026-07-10 close and re-opens the $91.02 July low. On fundamentals, the specific thing that breaks the leg is the margin claim: Q3 gross margin printing below 34% against the 35.0% ±1% guide would undercut the argument that the 2028 framework is arriving early, and revenue under the low end of $510M ±3% would end the sequential-acceleration story outright. A slip of the ElevATE close out of the 2H 2026 window, or a regulatory hold, removes the ATE optionality that was added on 2026-07-14. Conversely, a weekly close above $122.76 would complete the round trip and confirm the acceleration label rather than the maturing one.

Correlation Notes

• Analog/discrete cycle: ON Semiconductor, Microchip and Texas Instruments guidance remains the read-through for the automotive and industrial book, which mid-2026 coverage put near 44% of revenue.
• AI capex beta: Nvidia, Broadcom and the SOX index drive the multiple on risk days; the July 2026 drawdown was sector-wide rather than idiosyncratic.
• New ATE linkage: post-ElevATE, Teradyne and Advantest order commentary becomes a relevant second read on the acquired revenue line.
• Asia manufacturing footprint: China and Taiwan production exposure means tariff and cross-strait headlines can move the multiple independently of the order book.